These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9447652)

  • 1. Carcinogenesis models for risk assessment.
    Kopp-Schneider A
    Stat Methods Med Res; 1997 Dec; 6(4):317-40. PubMed ID: 9447652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioassay designs for validating biologically based mathematical models of carcinogenesis for risk assessment.
    Kodell RL
    Drug Metab Rev; 1996; 28(1-2):219-23. PubMed ID: 8744598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative risk assessment and the limitations of the linearized multistage model.
    Lovell DP; Thomas G
    Hum Exp Toxicol; 1996 Feb; 15(2):87-104. PubMed ID: 8645508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical research needs in mechanistic modelling for carcinogenic risk assessment.
    Portier C; el Masri H
    Stat Methods Med Res; 1997 Dec; 6(4):305-15. PubMed ID: 9447651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multistage models of carcinogenesis: an approximation for the size and number distribution of late-stage clones.
    Sherman CD; Portier CJ; Kopp-Schneider A
    Risk Anal; 1994 Dec; 14(6):1039-48. PubMed ID: 7846311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The time to tumor approach in risk assessment.
    Albert RE
    Basic Life Sci; 1986; 38():551-6. PubMed ID: 3741347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamental carcinogenic processes and their implications for low dose risk assessment.
    Crump KS; Hoel DG; Langley CH; Peto R
    Cancer Res; 1976 Sep; 36(9 pt.1):2973-9. PubMed ID: 975067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The linearized multistage model and the future of quantitative risk assessment.
    Crump KS
    Hum Exp Toxicol; 1996 Oct; 15(10):787-98. PubMed ID: 8906427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal experimentation and its relevance to man.
    Hoel DG
    Environ Health Perspect; 1979 Oct; 32():25-30. PubMed ID: 540597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk estimation--an overview: disease risk estimation based upon animal bioassays.
    Gaylor DW
    Drug Metab Rev; 1996; 28(1-2):9-27. PubMed ID: 8744587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships in chemical carcinogenesis reflect differences in individual susceptibility. Consequences for cancer risk assessment, extrapolation, and prevention.
    Lutz WK
    Hum Exp Toxicol; 1999 Dec; 18(12):707-12. PubMed ID: 10627656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Approach to Determining the Identifiability of Multistage Carcinogenesis Models.
    Brouwer AF; Meza R; Eisenberg MC
    Risk Anal; 2017 Jul; 37(7):1375-1387. PubMed ID: 27612302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of epidemiological observation in elucidating the mechanisms of carcinogenesis.
    Kaldor J
    IARC Sci Publ; 1992; (116):601-8. PubMed ID: 1428102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological data and multistage carcinogenesis.
    Day NE
    IARC Sci Publ; 1984; (56):339-57. PubMed ID: 6536599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methods of risk assessment from data of experimental carcinogenesis studies].
    Roller M; Csicsaky M; Pott F
    Zentralbl Hyg Umweltmed; 1992 Mar; 192(6):479-93. PubMed ID: 1315551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response problems in carcinogenesis.
    Crump KS
    Biometrics; 1979 Mar; 35(1):157-67. PubMed ID: 497333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symmetry, identifiability, and prediction uncertainties in multistage clonal expansion (MSCE) models of carcinogenesis.
    Cox LA; Huber WA
    Risk Anal; 2007 Dec; 27(6):1441-53. PubMed ID: 18093045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative evaluation for risk assessment of neoplasms caused by exposure to chemical substances].
    Szymczak W
    Med Pr; 2000; 51(6):625-36. PubMed ID: 11288691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.